$TRIL Perhaps I speak for most here? But are there any “bio expert types” invested here that can summarize what they learned today in terms of safety and efficacy? Ie. is this company heading in the right direction with a molecule that that definitely shows promising future? Or do the results show a real uphill battle. To a non- bio type like me the company info looks promising but I really don’t have any relevant understanding to compare it to what the FDA will need to see? Can anyone of expertise volunteer to comment? Thx.
5